Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Melbourne Theranostic Innovation Centre

Clinical trials sponsored by Melbourne Theranostic Innovation Centre, explained in plain language.

New scan agent shows promise for prostate cancer detection

Diagnosis Completed

This study tested a new imaging agent called 68Ga-NTA-476 for PET scans in 10 men with prostate cancer. The goal was to see how well it finds tumors compared to the standard scan, and to check for side effects. This was the first time this agent was used in humans, so safety and …

Early phase 1 • Sponsor: Melbourne Theranostic Innovation Centre • Aim: Diagnosis

Last updated Jun 27, 2026 07:51 UTC